-
11:37:49 AM

GMDA Stock News

05/31/23 7:00 AM
Nasdaq : GMDA
Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting
Gamida Cell Ltd., a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that an oral presentation highlighting Gamida Cell’ s investigational natural killer cell therapy candidate GDA-201 will be shared at the International Society for Cell and Gene Therapy 2023 Annual Meeting. The meeting takes place May 31- June 3 in...
RHEA-AI
neutral
05/11/23 5:20 PM
Nasdaq : GMDA
earnings
Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast
Gamida Cell Ltd., a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will host a conference call and live audio webcast on Monday, May 15, 2023, at 4:30 p.m. ET to review its first quarter 2023 financial results and provide an update on the company. To access the conference call, please register here and be...
RHEA-AI
neutral
04/17/23 4:16 PM
Nasdaq : GMDA
fda approval
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
Gamida Cell Ltd., a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the U.S. Food and Drug Administration has approved Gamida Cell’ s allogeneic cell therapy, Omisirge ®, for use in adult and pediatric patients 12 years and older with hematologic malignancies planned for umbilical cord blood transplantation...
RHEA-AI
neutral
03/27/23 7:00 AM
Nasdaq : GMDA
earnings
Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update
Gamida Cell Ltd., a cell therapy pioneer working to turn cells into powerful therapeutics, today provided a business update and reported financial results for the year ended December 31, 2022. As of December 31, 2022, Gamida Cell had total cash and cash equivalents of $64.7 million. “Our mission is to bring potentially curative therapies to patients,” said Abbey...
RHEA-AI
neutral